ARCHIVES

NCI Changes Deadlines For Two RFAS

This article is from The Cancer Letter archive.

Vol. 23 No. 28 | July 18, 1997

Download PDF Visit The Full Archive

Related Articles

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

In Brief: HHS Implements Debarment Regulations; Joftes, Cain Head New NCI contract, Grants Branches

October 24, 1980

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

August 9, 2013